Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer
2015/02/03 by Kurt A. Schalper, Jason R. Brown, Jason Brown +7 · 432 citations
Immunology and Microbiology · Medicine · #Biology #CD8 #Cancer #Cancer Immunotherapy and Biomarkers #Cytokeratin #Immune Cell Function and Interaction #Immune system #Immunohistochemistry #Immunology #Immunotherapy #Immunotherapy and Immune Responses #Internal medicine #Lung cancer #Medicine #Multivariate analysis #Oncology #Pathology #Stage (stratigraphy) #Tissue microarray #Tumor-infiltrating lymphocytes #Univariate analysis
paper · open access · doi:10.1093/jnci/dju435
published in JNCI Journal of the National Cancer Institute 107(3) (Oxford University Press)
openalex publication_date 2015/02/03 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
Abstract
BACKGROUND: Tumor-infiltrating lymphocytes (TILs) are usually measured using subjective methods. Studies suggest that TIL subtypes have independent roles in cancer and that they could support the use of novel immunostimulatory therapies. We simultaneously measured TIL subtypes in non-small cell lung cancer (NSCLC) samples using objective methods and determined their relationship with clinico-pathologic characteristics and survival. METHODS: Using multiplexed quantitative fluorescence (QIF), we measured the levels of CD3, CD8, and CD20 in 552 NSCLC from two independent collections represented in tissue microarrays (YTMA79, n = 202 and YTMA140, n = 350). The level of TILs was obtained in different tumor compartments using cytokeratin stain to define tumor cells and 4',6-Diamidino-2-Phenylindole. Association of TILs with clinical parameters was determined using univariate and multivariable analyses. All statistical tests were two-sided. RESULTS: In both NSCLC collections there was a low correlation between the three TIL markers (linear regression coefficients (R(2)) = 0.19-0.22, P < .001 for YTMA79 and R(2) = 0.23-0.32, P < .001 for YTMA140). No consistent association between the level of TIL subtypes and age, sex, smoking history, tumor size, stage, and histology type was found. In univariate analysis, an elevated CD3 or CD8 signal was statistically significantly associated with longer survival in both collections. However, only CD8 was independent from age, tumor size, histology, and stage in multivariable analysis. High CD20 was associated with longer survival in the YTMA79 cohort. CONCLUSIONS: Increased levels of CD3 and CD8 + TILs are associated with better outcome in NSCLC, but only CD8 is independent from other prognostic variables. Objective measurement of TIL subpopulations could be useful to predict response or evaluate the local immune effect of anticancer immune checkpoint inhibitors.
Citations
Cited by
- Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
- AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma
- Single-cell and bulk RNA sequencing data jointly reveals VDAC2’s impacts on prognosis and immune landscape of NSCLC
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. [europepmc]
- Classifying Cancers Based on T-cell Infiltration and PD-L1. [europepmc]
- Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer. [europepmc]
- Biomarker development in the precision medicine era: lung cancer as a case study. [europepmc]
- Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer. [europepmc]
- Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape. [europepmc]
- Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors. [europepmc]
- The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis. [europepmc]
- Implications of the tumor immune microenvironment for staging and therapeutics. [europepmc]
- Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer. [europepmc]
- Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer. [europepmc]
- Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer. [europepmc]
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3. [europepmc]
- Immune Cell Composition in Human Non-small Cell Lung Cancer. [europepmc]
- Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes. [europepmc]
- Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC). [europepmc]
- Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis. [europepmc]
- Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis. [europepmc]
- High-Plex Predictive Marker Discovery for Melanoma Immunotherapy-Treated Patients Using Digital Spatial Profiling. [europepmc]
- Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy. [europepmc]
- Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial. [europepmc]
- Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors. [europepmc]
- Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma. [europepmc]
- The β 1 -adrenergic receptor links sympathetic nerves to T cell exhaustion. [europepmc]
- Cancer biomarkers: Emerging trends and clinical implications for personalized treatment. [europepmc]
Related